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Avian leukosis virus (ALV) requires endocytosis and a low pH step for successful viral entry. Here we report that transient treatment with
lysosomotropic agents was not sufficient to block ALV subgroup B (ALV-B) entry, while it completely inhibited uptake of the pH-dependent
Semliki Forest virus. Extended incubations with lysosomotropic agents were required to block ALV-B entry, suggesting that ALV particles
are stable in endosomal compartments. We analyzed endocytic pathways involved in the uptake of ALV-B into target cells. The ALV-B
receptor TVBS3 was not associated with detergent-resistant membranes (DRMs) in the presence or absence of ALV-B particles. This result
suggested that DRM-associated endocytic pathways were not required for ALV-B entry. Using several approaches, we found that clathrin
mediates endocytosis of ALV-B particles into target cells. By means of confocal microscopy, we established that the ALV-B receptor TVBS3
colocalized with clathrin in TVBS3-expressing quail QT-6 cells. In addition, chlorpromazine, an inhibitor of clathrin-mediated endocytosis,
blocked uptake of soluble ALV-B Env into chicken embryo fibroblasts. To examine ALV-B uptake into clathrin-negative cells, we used a
chicken DT40 B cell line containing a tetracycline-regulatable clathrin gene. Clathrin depletion significantly reduced ALV-B entry into the
chicken DT40 cell line. Taken together, our results suggest that clathrin is involved in uptake of ALV-B particles into target cells.
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Infection of target cells by avian leukosis virus (ALV)
has been used as a model system to study retroviral entry.
The first step of ALV entry is binding of the viral envelope
glycoprotein (Env) to a specific cellular receptor. ALV Env
binding to its cognate receptor triggers a pH-independent
conformational change of the viral Env (Earp et al., 2003;
Matsuyama et al., 2004; Netter et al., 2004; White, 1995).
Interestingly, lipid mixing of ALV and cellular membranes
occurred at neutral pH (Earp et al., 2003). In addition,
syncytia formation of ALV Env-expressing cells with ALV0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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neutral pH (Earp et al., 2003). Several findings suggest that
an additional pH-dependent step is required for productive
ALV infection: (i) mild acidic conditions significantly
enhance syncytia of viral Env-expressing cells with ALV
receptor-expressing cells (Earp et al., 2003; Melikyan et al.,
2004; Mothes et al., 2000); (ii) low pH in the presence of the
cognate ALV receptor triggers the formation of stable ALV
Env transmembrane protein oligomers (Mothes et al., 2000;
Smith et al., 2004); and (iii) lysosomotropic agents, which
prevent the acidification of endosomal compartments,
inhibit ALV entry (Diaz-Griffero et al., 2002; Mothes et
al., 2000). However, the endocytic machinery involved in
ALV uptake remains to be identified.
ALV is divided into 10 major subgroups, designated A
through J. Cellular receptors have been identified for ALV
subgroups A, B, D, and E. The low-density lipoprotein
(LDL)-like receptor TVA mediates entry of ALV-A (Bates et005) 45 – 54
F. Diaz-Griffero et al. / Virology 337 (2005) 45–5446al., 1993), and a family of TNFR-related receptors (TVBS3,
TVBS1, and TVBT) confers susceptibility to ALV subgroups
B, D, and E (Adkins et al., 1997, 2000; Brojatsch et al.,
1996). TVBS3, the receptor for cytopathic ALV-B/D, con-
tains 3 extracellular cysteine-rich domains, a transmemb-
rane-spanning domain, and a cytoplasmic region, which
includes an 80 amino acid ‘‘death domain’’ that is essential
for ALV-B-mediated cytopathic effects (Diaz-Griffero et al.,
submitted for publication; Tartaglia et al., 1993). The ALV-
B Env binds to a linear extracellular epitope of TVBS3
corresponding to residues 32–46 (Knauss and Young,
2002). The native ALV Env is a trimer of heterodimers,
which are composed of the surface unit (SU) and the
transmembrane unit (TM). ALV Env TM presents structural
similarities with the Env of influenza A virus, specifically
the hemagglutinin 2 subunit (HA-2). The influenza A virus
is a highly characterized pH-dependent virus, and low pH
triggers a conformational change of the HA-2 protein
(Skehel and Wiley, 2000; Weissenhorn et al., 1999). This
conformational change triggers the exposure of a fusion
peptide, which mediates virus-to-cell membrane fusion
(Bullough et al., 1994; Carr and Kim, 1993; Durrer et al.,
1996; Stegmann et al., 1990).
The low pH environment of endocytic compartments is
required for successful fusion by certain viruses (Maxfield
and Yamashiro, 1987; McClure et al., 1990). The pH-
dependence suggests that endocytosis of viral particles to
acidic compartments is required for productive infection.
Endocytosis appears to be essential for productive ALV
infection, as dominant-negative dynamin blocks ALV entry
(Mothes et al., 2000), and ALV particles are found in
endosomes (Diaz-Griffero et al., 2002).
Several types of endocytic pathways have been described
for viral uptake into target cells, including clathrin-mediated
endocytosis, detergent-resistant membrane (DRM)-mediated
endocytosis, macropinocytosis, and phagocytosis (Sieczkar-
ski and Whittaker, 2002; Smith et al., 2004). Clathrin-
mediated endocytic pathways are involved in the uptake of
several enveloped viruses, including Sindbis virus (DeTul-
leo and Kirchhausen, 1998), Semliki Forest virus (SFV)
(Doxsey et al., 1987), and human polyoma virus JC virus
(Pho et al., 2000; Querbes et al., 2004). Interaction of
clathrin-dependent viruses with surface receptors triggers
the sequential recruitment of downstream adaptor proteins
and the formation of clathrin-coated pits. Subsequently,
clathrin-coated vesicles transfer viral particles to the acidic
environment of endosomes, where viral fusion occurs
(Marsh and Pelchen-Matthews, 2000). Some viruses,
including simian virus 40, polyoma virus, and ALV-A
(Narayan et al., 2003; Pelkmans and Helenius, 2002), can be
endocytosed into target cells via DRMs, such as caveolae or
rafts. The GPI-anchored form of the ALV-A receptor,
TVA800, is associated with DRMs (Bates et al., 1993;
Narayan et al., 2003). Caveolae are characterized by their
enrichment in sphingolipids, cholesterol, and cholesterol
binding proteins (Kurzchalia and Parton, 1999). Clathrin-independent and caveolae-independent endocytic pathways
are involved in the uptake of influenza virus and SV40
(Damm et al., 2005; Sieczkarski and Whittaker, 2002).
Other viruses, including adenovirus and HIV, can be
internalized via macropinocytosis, an endocytic mechanism
mediated by the formation of large vesicles (Marechal et al.,
2001; Meier et al., 2002).
In this study, we demonstrated that extended treatment of
target cells with lysosomotropic agents is required to inhibit
ALV-B entry while transient exposure to these agents proves
insufficient. These results suggest that ALV-B particles are
stable in endosomal compartments in the presence of
lysosomotropic agents. We found that ALV-B uses cla-
thrin-mediated endocytic pathways to enter target cells. This
was supported by experiments showing that clathrin
colocalized with the ALV-B receptor TVBS3 and that
clathrin depletion blocked ALV-B entry into avian cell
lines. In contrast to clathrin, DRM-associated caveolin-1
was not required for TVBS3 trafficking and ALV-B entry.Results
ALV-B is stable in intracellular compartments
Use of lysosomotropic agents, which prevent the acid-
ification of endosomal compartments, inhibit productive
ALV infections (Diaz-Griffero et al., 2002; Earp et al., 2003;
Mothes et al., 2000). The efficiency of lysosomotropic
agents in blocking ALV entry is subgroup-specific and
receptor-dependent. Transient treatment with lysosomo-
tropic agents was only minimally effective in blocking
ALV-A entry into cells expressing the ALV-A receptor
TVA800 (Narayan et al., 2003). We hypothesized that
extended incubation times with lysosomotropic agents are
required for productive ALV infection. To test this, we
challenged human HEK 293 cells expressing the ALV-B
receptor TVBS3 with pseudotyped murine leukemia virus
(MLV) particles bearing the envelope glycoprotein (Env) of
ALV-B. As controls, we used MLV particles bearing either
the Env of pH-dependent SFV or pH-independent ampho-
tropic MLV. The pseudotyped MLV particles express the
firefly luciferase protein upon infection. 293-TVBS3 cells
were infected with pseudotyped MLV particles in the
presence of the lysosomotropic agent NH4Cl. At different
time points, the NH4Cl-containing media were replaced
with drug-free media, and luciferase activity was measured
48 h postinfection. As expected, entry of MLV particles
pseudotyped with SFV Env into 293-TVBS3 cells was
blocked efficiently in the presence of NH4Cl. Incubation
times of 1 h with lysosomotropic agents were sufficient to
completely block (> 95%) entry of SFV pseudotypes,
indicating rapid and efficient inhibition of SFV entry by
these agents (Fig. 1A).
In contrast to SFV pseudotypes, entry of MLV particles
pseudotyped with ALV-B Env into 293-TVBS3 cells
Fig. 1. ALV-B is stable in intracellular compartments. 293T cells expressing
TVBS3 were challenged with MLV particles pseudotyped with the envelope
protein of SFV (A), ALV-B (B), and amphotrophic MLV (C) in the
presence or absence of 50 mM NH4Cl. The amount of virus used was
normalized by luciferase activity produced 48 h postinfection, and 105
relative light units were used per individual infection. At the indicated
times, viral particles and NH4Cl were replaced with fresh media. Luciferase
activity was measured in total cellular extracts 48 h postinfection, and
mock-treated samples correspond to 100% of luciferase activity. Experi-
ments were performed in triplicates, and standard deviations are shown.
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Ammonium chloride treatment for 2 h or less was
insufficient to block entry of ALV-B Env pseudotyped
viruses into target cells (Fig. 1B). Approximately 8 h of
NH4Cl treatment was required to inhibit more than 80% of
ALV-B entry (Fig. 1B). In agreement, we have previously
reported that ALV-B entry was efficiently blocked after 4 h
of treatment with NH4Cl (Diaz-Griffero et al., 2002).
Prolonged ammonium chloride treatment was not toxic, as
NH4Cl treatment of 293-TVB
S3 cells for up to 24 h did not
inhibit infection of MLV particles pseudotyped with theamphotropic MLV Env (Fig. 1C). Intriguingly, NH4Cl
treatment increased infection of amphotropic MLV Env-
pseudotyped viruses.
These results indicated that ALV-B particles are stable in
endosomal compartments in the presence of lysosomotropic
agents and remain infectious after transient treatment with
NH4Cl. To understand the mechanism by which ALV-B
particles are internalized, we investigated endocytic path-
ways involved in ALV-B entry.
DRM-associated proteins are not involved in
TVBS3-trafficking
The ALV-B receptor TVBS3 is a member of the TNFR
family. The mammalian TNFR-1 is associated with DRMs
through the cytoplasmic death domain (Cottin et al., 2002;
Jones et al., 1999). To test whether TVBS3 is associated with
DRMs, we performed flotation assays. DF-1 cells were
lysed with a Triton X-100 containing buffer and cellular
lysates were subjected to a discontinuous sucrose density
gradient centrifugation (5–40%). DRM-associated proteins,
such as caveolin-1, float towards the top of the sucrose
gradient, whereas detergent-soluble fractions move to the
bottom of the gradient (Scherer et al., 1994). Following
ultracentrifugation, protein fractions were collected and
analyzed for TVBS3 and caveolin-1 expression by Western
blotting using SUB-IgG and anti-caveolin-1 antibodies,
respectively. TVBS3 was found predominantly in the
detergent-soluble fractions 8 through 12, while caveolin-1
was present in detergent-insoluble fractions 3 through 9
(Fig. 2A). The differential fractionation of TVBS3 and
caveolin-1 indicated that TVBS3 was not associated with
DRMs (Fig. 2A). In the case of the glial cell-derived
neurotropic receptor and the MHC class II receptor, ligand
binding triggers translocation of these receptors to DRMs
(Simons and Toomre, 2000). Therefore, we tested whether
binding of ALV-B particles alters the cellular localization of
TVBS3 and recruitment to DRMs. We found that TVBS3 did
not shift towards the insoluble fractions in the presence of
high titer ALV-B particles (Fig. 2B). Our findings are
consistent with the susceptibility to ALV-B infection of
caveolin-1-negative human astrocytoma (U-251) cells
expressing the ALV-B receptor TVBS3 (Diaz-Griffero et
al., 2002). These results suggested that TVBS3 is not
associated with DRMs and that ALV-B entry does not
require DRMs. This is in contrast to ALV-A, which could
enter target cells via the DRM-associated GPI-anchored
ALV-A receptor TVA800 (Narayan et al., 2003).
TVBS3 colocalized with clathrin
We have previously observed ALV-B particles in
clathrin-coated vesicles, suggesting involvement of clathrin
in ALV-B entry (Diaz-Griffero et al., 2002). In order to test
the role of clathrin in TVBS3 trafficking and ALV-B entry,
we investigated whether TVBS3 is associated with clathrin.
Fig. 3. TVBS3 colocalizes with clathrin and TGN. QT-6 cells expressing
V5-tagged TVBS3 were immunostained for TVBS3 and clathrin using anti-
V5 and anti-clathrin antibodies, respectively (A and B). Human astrocy-
toma cells expressing TVBS3 were immunostained for TVBS3 and TGN
using SUB-IgG and anti-TGN46 antibodies, respectively (C and D).
Confocal images of untreated (C) and brefeldin A-treated (D) astrocytoma
cells are shown. Colocalization is shown in yellow.
Fig. 2. TVBS3 is not associated with DRMs in the presence or absence of
ALV-B. DF-1 cells were incubated with ALV-B at an MOI of 100 (B) or
mock treated (A). After 30 min, cells were homogenized in a Triton X-100
detergent solution and fractionated by discontinuous sucrose gradient
centrifugation (5–40%). Gradient fractions 1–12 were analyzed for the
presence of TVBS3 and caveolin-1 by Western blotting using SUB-IgG and
anti-caveolin-1 antibodies, respectively.
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into the mammalian expression vector pEF6/V5-His TOPO.
This construct fused a 14-amino acid V5 epitope and a
polyhistidine (6xHis) tag to the C-terminus of TVBS3. The
V5-tagged TVBS3-fusion protein was stably expressed in
QT-6 cells (Figs. 3A and B) and used for colocalization
studies. TVBS3 and clathrin heavy chains were visualized by
using anti-V5 and anti-clathrin antibodies, respectively.
Confocal images illustrated extensive colocalization of
TVBS3 with the clathrin heavy chain in TVBS3-expressing
QT-6 cells (Figs. 3A and B). TVBS3 and clathrin shared
punctuate staining on the plasma membrane of these cells
(Fig. 3A, see inserted box). Cross-sections of TVBS3-
expressing QT-6 cells revealed perinuclear localization of
the receptor with clathrin (Fig. 3B).
Intracellular clathrin has been reported to localize to the
trans-Golgi network (TGN) (Carreno et al., 2004). More-
over, other members of the death receptor family such as
TNFR-1 are predominantly associated with the TGN (Jones
et al., 1999). Therefore, we tested whether intracellular
TVBS3 is associated with the TGN. Since TGN markers are
better characterized in human cells, we performed local-
ization experiments in our previously described human U-
251 cells expressing TVBS3 (Diaz-Griffero et al., 2002). We
found that perinuclear TVBS3 colocalized extensively with
the TGN marker TGN46 (Fig. 3C). TGN localization of
TVBS3 was confirmed by using brefeldin A, an inhibitor of
anterograde vesicular transport from the ER to the TGN and
between TGN stacks (Lippincott-Schwartz et al., 1990).
Brefeldin A treatment collapses the majority of the TGN
around the microtubule organizing center (Reaves and
Banting, 1992). Brefeldin A (5 Ag/ml) treatment ofTVBS3-expressing astrocytoma cells for 1 h resulted in
perinuclear accumulation of TVBS3 and colocalization with
the TGN (Fig. 3D). Taken together, our results indicated that
TVBS3 colocalizes with clathrin on the plasma membrane
and with the TGN in intracellular compartments.
Clathrin inhibitors block internalization of soluble ALV-B
Env
We have previously shown that chlorpromazine, an
inhibitor of clathrin-mediated endocytosis, blocks ALV-B
infection (Diaz-Griffero et al., 2002). This cationic amphi-
philic drug disrupts endocytosis by relocating clathrin and
the adaptor protein AP2 from the cell surface (Wang et al.,
1993). To determine whether chlorpromazine blocked ALV
entry by inhibiting endocytosis of TVBS3, we performed
internalization studies using a soluble form of the ALV-B
Env protein (SUB-IgG) by confocal microscopy. SUB-IgG
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to the Fc portion of the rabbit IgG heavy chain (Brojatsch et
al., 1996). After prebinding DF-1 cells with purified SUB-
IgG at 4 -C, endocytosis of soluble ALV-B Env was induced
by shifting the temperature to 37 -C. ALV-B Env internal-
ization in the presence or absence of chlorpromazine was
analyzed by confocal microscopy using Cy3-labeled secon-
dary anti-rabbit antibodies.
After incubation at 4 -C, SUB-IgG was present predom-
inantly at the plasma membrane (Fig. 4A), and upon shifting
the temperature to 37 -C, we observed perinuclear local-
ization of SUB-IgG, indicating internalization of ALV-B
Env (Figs. 4B and C). In contrast, internalization of SUB-
IgG was not detected in chlorpromazine-treated cells (Figs.
4D–F). This result is consistent with our previous findings
that chlorpromazine efficiently inhibited ALV-B entry into
target cells (Diaz-Griffero et al., 2002; Mothes et al., 2000).
Chlorpromazine blockage of ALV-B Env uptake suggested
that this process is mediated by clathrin.
Clathrin depletion inhibits ALV-B uptake
As a final and more conclusive approach to study clathrin
involvement in ALV-B entry, we employed a genetic
strategy. To deplete cells of the clathrin heavy chain protein,
we took advantage of a chicken B cell line, DT40, which
was engineered to lack both endogenous alleles of clathrin.
These clathrin-negative cells express the human clathrin
heavy chain under the control of a tetracycline-regulatable
promoter (Tet-Off system) (Wettey et al., 2002). The
tetracycline-regulatable promoter controls the firefly luci-
ferase gene, in addition to the clathrin heavy gene, toFig. 4. Uptake of soluble ALV-B Env is blocked by chlorpromazine. DF-1 cells w
Internalization was measured in the presence (A–C) or absence (D–F) of chlorp
immunostained using an anti-rabbit Cy3-labeled antibody as described in Materiamonitor the efficiency of these regulatory regions. Doxycy-
cline treatment completely abrogated luciferase expression
in two independent DT40 cell lines, DKO-S and DKO-R
cells (Fig. 5A). These DT40 clones differ in their
responsiveness to clathrin depletion. Extended clathrin
depletion kills DKO-S cells, while DKO-R cells remain
viable in the absence of clathrin for several days (Wettey et
al., 2002). To address the role of clathrin in ALV-B entry, we
depleted DKO-S and DKO-R cells of clathrin by treatment
with 1 Ag/ml of doxycycline. Doxycycline treatment sup-
pressed clathrin expression in both cell lines 96 h after
treatment (Fig. 5B). Clathrin-depleted cells were challenged
by ALV-B expressing the green fluorescent protein (ALV-B-
eGFP) at a multiplicity of infection of 5. In the case of
DKO-S cells, we removed doxycycline 24 h after infection
to ensure survival of these cells. ALV-B-eGFP uptake was
measured by analyzing GFP expression using flow cytom-
etry 48 h postinfection. In both cell lines, clathrin depletion
led to a significant reduction of ALV-B uptake (Fig. 5C). As
expected, clathrin depletion did not affect entry of ampho-
tropic MLV (Fig. 5C), suggesting that the inhibition of
ALV-B entry is specific and not due to pleiotropic effects
caused by cathrin depletion.
Residual ALV-B uptake into clathrin-depleted DT40 cells
was presumably mediated by alternative pathways, includ-
ing clathrin-independent pinocytosis, which are upregulated
30 min after clathrin-mediated endocytosis is inhibited
(Damke et al., 1995). Consistent with our findings, re-
cycling of chicken transferrin, which is mediated by cla-
thrin, is reduced to a similar extent after clathrin elimination,
suggesting residual trafficking of transferrin via clathrin-
independent pathways (Wettey et al., 2002). Taken together,ere incubated with 50 ng of soluble ALV-B Env (SUB-IgG) for 1 h at 4 -C.
romazine 50 AM 0, 30, and 60 min postinfection. Soluble ALV-B Env was
ls and methods. The cellular nucleus is indicated by ‘‘n’’.
Fig. 5. Clathrin heavy chain depletion blocks ALV-B entry. Clathrin
depletion was induced in DKO-R and DKO-S cells using doxycycline
(1 Ag/ml) for 96 h. Luciferase activity was determined using cellular
extracts from 1105 cells treated with 1 Ag/ml of doxycycline for 96 h (A).
Cellular extracts from doxycycline-treated DKO-R, DKO-S, and parental
DT-40 cells were used to detect the presence of clathrin heavy chain protein
by Western blot analysis using anti-clathrin heavy chain antibodies (B).
Untreated and doxycycline-treated DKO-R and DKO-S cells were
challenged with ALV-B and amphotropic MLV pseudotypes at an MOI
of 5. Infection was measured by analysis of eGFP expression using flow
cytometry 48 h postinfection (C).
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mediated endocytosis are crucial for ALV-B entry into target
cells.Discussion
Entry of pH-dependent viruses into target cells is a
multistep process where cell attachment and internalization
represent spatio-temporally distinct steps. Mounting evi-
dence suggests that ALV entry into target cells is a two-step
process. Binding of ALV Env to its cognate receptor triggersa pH-independent conformational change, which is followed
by endocytosis of ALV particles (Diaz-Griffero et al., 2002;
Mothes et al., 2000). Previous reports have shown that lipid
mixing, an early stage of viral fusion, is non-responsive to
lysosomotropic agents (Earp et al., 2003; Gilbert et al.,
1990). However, productive ALV infection requires a low
pH step (Diaz-Griffero et al., 2002; Mothes et al., 2000;
Narayan et al., 2003), and it remains to be shown whether a
low pH phase promotes a step prior to lipid mixing or is
required for pore formation (Earp et al., 2003). We found
that transient treatment with lysosomotropic agents was
insufficient to block ALV-B entry, and treatment for at least
8 h was required to inhibit ALV-B uptake significantly. This
in agreement with a previous report showing that transient
treatment with lysosomotropic agents does not block ALV-
A entry (Earp et al., 2003), while continuous treatment with
these agents strongly inhibits ALV-A and ALV-B entry
(Barnard et al., 2004; Mothes et al., 2000; Narayan et al.,
2003). However, lysosomotropic agents do not block lipid
mixing of ALV membranes and target cell membranes (Earp
et al., 2003; Gilbert et al., 1990). This suggests that ALV-B
particles are stable in intracellular compartments and that
early replacement of lysosomotropic drugs allows fusion of
viral particles in intracellular compartments. Our findings
show that ALV-B is stable in endocytic compartments,
consistent with experiments described for ALV-A (Earp et
al., 2003; Narayan et al., 2003). Presumably, lysosomotropic
agents prevent ALV-B fusion with endocytic membranes
and arrest ALV-B particles in an infectious state. The slow
kinetics, by which lysosomotropic agents block ALV-B
entry, are in stark contrast to the effect of these drugs on
SFV uptake. SFV entry is completely abrogated by short
treatment with these inhibitors, suggesting that SFV, unlike
ALV-B, is endocytosed to a different intracellular compart-
ment, where it is rapidly inactivated, even in the presence of
lysosomotropic agents (Diaz-Griffero et al., 2002). The
stability of ALV-B in endosomes is shared by ALV-A, when
ALV-A is internalized by TVA800 (Narayan et al., 2003).
ALV-A entry is mediated by two alternative receptors,
TVA800 and TVA950. ALV-A particles internalized via the
GPI-anchored TVA800 are stable in intracellular compart-
ments and remain highly infectious for more than 6 h in the
presence of the lysosomotropic agent ammonium chloride
(Narayan et al., 2003). In contrast, ALV-A, endocytosed via
TVA950, is rapidly degraded in the presence of ammonium
chloride (Narayan et al., 2003). Taken together, our results
support the hypothesis that ALV entry is pH-dependent and
that extended incubations with lysosomotropic agents are
required to block ALV entry. It is conceivable that ALV
particles undergo hemifusion at neutral pH (Earp et al.,
2003) and that low pH is required to open fusion pores and
complete the fusion process.
Lysosomotropic agents arrest ALV-B particles in endo-
somes and appear to prevent lysosomal degradation of these
viral particles. Endocytosis and lysosomal degradation also
play a role in entry of MLV and HIV. For example, the
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lysosomotropic agents, suggesting that HIV is rapidly
endocytosed and degraded in lysosomes (Fredericksen et
al., 2002). In agreement with this, we demonstrated that the
infectivity of amphotropic MLV increases upon treatment
with lysosomotropic agents (Fig. 1C). Aside from degrada-
tion of endocytosed viruses in lysosomal compartments, it
has been suggested that infectious viral particles can also be
stored in intracellular compartments (Geijtenbeek et al.,
2000). For example, HIV-1 particles accumulate in MHC
class II compartments of macrophages (Raposo et al., 2002)
and can be stored in intracellular compartments of dendritic
cells for several days to infect T cells subsequently (Kwon et
al., 2002; McDonald et al., 2003).
The pH dependence of ALV fusion suggests that
endocytosis provides the acidic environment for ALV
fusion and productive infections. Several findings suggest
that endocytosis of ALV-B particles is essential for
productive viral infections: (i) ALV entry is pH-dependent,
as shown by inhibition studies using lysosomotropic agents
and by syncytia formation of ALV-infected cells at acidic
pH (Diaz-Griffero et al., 2002; Melikyan et al., 2004;
Mothes et al., 2000); (ii) dominant-negative dynamin
reduces ALV entry into target cells (Mothes et al., 2000);
(iii) ALV particles are found in endocytic compartments
(Diaz-Griffero et al., 2002). Despite promoting ALV
fusion, we have preliminary evidence that pH could play
an additional role in ALV entry. We found that protease
inhibitors block ALV-B entry (data not shown), suggesting
that proteases are involved in this process. The proteolytic
activity of several cellular proteases is pH dependent and
could be blocked by lysosomotropic agents. We are
currently investigating the role of cellular proteases in
ALV-B entry.
Several lines of evidence suggest that ALV-B uptake is
clathrin-dependent: (i) the ALV-B receptor TVBS3 coloca-
lized with clathrin; (ii) ALV particles were found in clathrin-
coated vesicles in chicken embryo fibroblasts (Diaz-Griffero
et al., 2002); (iii) uptake of ALV-B particles (Diaz-Griffero
et al., 2002) and soluble ALV-B Env into target cells was
blocked by the clathrin-mediated uptake inhibitor chlorpro-
mazine; and (iv) transient clathrin depletion reduced ALV-B
entry into target cells.
Our results show significant but incomplete reduction of
ALV-B entry into DT40 cells after clathrin depletion. This
result is consistent with data showing that complete clathrin
elimination reduced transferrin trafficking only by 30–40%
(Wettey et al., 2002). Since transferrin is a classic marker for
clathrin-mediated uptake, these results suggested that alter-
native endocytic pathways are activated after clathrin
elimination. These alternative pathways are likely to allow
residual ALV-B and transferrin uptake. We demonstrated
that the clathrin-mediated uptake inhibitor chlorpromazine
completely abrogates ALV-B entry and uptake of soluble
ALV-B Env into target cells, while residual ALV B uptake
occurred in DT40 cells after clathrin depletion. Presumablyalternative endocytic pathways are not induced in cells
following transient chlorpromazine treatment, while these
pathways are activated in cells following extended clathrin
depletion (Damke et al., 1995). The same phenomenon was
observed with transferrin trafficking, which was completely
blocked by chlorpromazine (Wang et al., 1993), while it was
incompletely reduced after clathrin depletion (Wettey et al.,
2002). It is unknown which endocytic pathways are
upregulated and responsible for residual ALV-B uptake in
DT40 cells after clathrin depletion.
Our results suggest that ALV-B Env/TVBS3 interactions
lead to the recruitment of clathrin and associated adaptor
proteins, such as AP2 to the cytoplasmic tail of TVBS3,
and subsequent formation of clathrin-coated pits. Intrigu-
ingly, the cytoplasmic tail of TVBS3 contains several
putative internalization signals, including 4 dileucine
motifs, at positions 204, 228, 272, and 337 in TVBS3,
and 2 tyrosine-based motifs (YXXØ), at positions 283 and
318 in TVBS3. One of the tyrosine-based motifs, position
318 in TVBS3, is highly conserved among members of
the TNFR family including TNFR-1 and Fas (Brojatsch et
al., 1996). This suggests that the cytoplasmic tail of
TVBS3 is directly involved in receptor trafficking and
ALV-B entry.
Our studies showed that TVBS3 is not associated with
DRMs and caveolin-1. This is in contrast to the GPI-
anchored form of the ALV-A receptor TVA800, which is
associated with DRMs (Narayan et al., 2003). TVA800 and
TVBS3 internalize ALV particles to endocytic compart-
ments, where viruses remain infectious upon treatment
with lysosomotropic agents. In contrast, a second ALV-A
receptor (TVA950), which, like TVBS3, is not associated
with rafts, transports ALV-A particles to cellular compart-
ments where ALV-A is rapidly degraded (Narayan et al.,
2003). Future work will address if both TVA800 and
TVBS3 receptors transport viruses to a similar intracellular
compartment.Materials and methods
Cell lines, reagents, and antibodies
DF-1 chicken embryo fibroblasts, human 293T cells
expressing TVBS3, and human U-251 astrocytoma cells
expressing TVBS3 have been described previously (Diaz-
Griffero et al., 2002). Cells were grown in complete
Dulbecco’s modified Eagle media (DMEM media; Medi-
atech) supplemented with 10% fetal bovine serum, 2 mM l-
glutamine, penicillin (100 U/ml), and streptomycin (100 Ag/
ml). Ammonium chloride, chlorpromazine, brefeldin A, and
doxycycline were obtained from Sigma. Fifty millimolar
ammonium chloride, 50 AM chlorpromazine, 5 Ag/ml
brefeldin A, and doxycycline (1 Ag/ml) were used in the
inhibition experiments. These inhibitors did not affect the
pH of the cellular media at the indicated concentrations.
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TD.1 isotype IgG2a was obtained from Sigma-Aldrich.
Mouse monoclonal serum anti-V5 isotype IgG1 was
obtained from Invitrogen. Monoclonal serum anti-mouse
IgG1-alexa 555 and IgG2a-alexa 488 were obtained from
Molecular Probes. Monoclonal serum against TGN 46 was
obtained from Zymed. Serum anti-rabbit Cy3-labeled and
anti-mouse Cy2-labeled antibodies were obtained from
Jackson Immunoresearch. Two DT40 cell lines, DKO-S
and DKO-R cells, lack both endogenous clathrin alleles and
express the human clathrin heavy chain under the control of
a tetracycline-regulatable promoter (Tet-Off system) (Wet-
tey et al., 2002). DKO-S cells are highly sensitive to clathrin
depletion, while DKO-R cells remain viable for several days
in the absence of clathrin (Wettey et al., 2002). These cell
lines were used as described previously (Wettey et al.,
2002). ALV-B virus was produced by transfecting DF-1
cells with pRCASBP(B)-eGFP (Mothes et al., 2000).
Supernatants were collected 48 h after transfection and
stored at 80 -C. Viral titers were determined by endpoint
dilution assays.
Production of MLV pseudotyped particles
A total of 4  106 GP-2-293 cells seeded on 100-mm
tissue culture plates were cotransfected with 5 Ag of
pLAPSN (Luciferase reporter; Clontech) or 5 Ag of
QNCeGFP (eGFP reporter; Clontech) and 5 Ag of enve-
lope-expressing plasmids using the calcium phosphate
procedure as described in the manual for the pantropic
Retroviral Expression System (Clontech). GP-2-293 cells
stably express gag and pol genes of murine leukemia virus
(Clontech). Pseudotyped particles were collected 48 h after
transfection and stored at 80 -C. SFV Env and murine
leukemia virus (amphotropic MLV) Env-expressing plas-
mids were obtained from Tanya Dragic (Albert Einstein
College of Medicine, Bronx, NY). Pseudotype viruses
expressing the eGFP as a reporter were tittered by endpoint
dilution assays.
Viral entry and luciferase assays
Pseudotyped viruses were prebound to 1  105 cells on
24-well tissue culture plates at 4 -C for 1 h. Supernatants
were replaced with fresh media containing lysosomotropic
agents and incubated at 37 -C for different times.
Subsequently, media were replaced with complete medium,
and cellular extracts were prepared 48 h after infection to
assay for luciferase activity. Extracts were made using 250
Al of luciferase lysis buffer (Promega), and after 1 freeze/
thaw cycle, samples were centrifuged at 12,000  g for 5
min. Ninety microliters of the supernatant was mixed with
30 Al of the luciferase substrate (Promega) and incubated
for 3 min at room temperature. Luciferase activity was
measured using a luminometer (Perkin-Elmer Wallac). To
assay entry of ALV-B in DKO-R and DKO-S cells, weused flow cytometry. A total of 1  105 infected DKO-R
or DKO-S cells were analyzed with a FACSCalibur flow
cytometer in the FL-1 channel to detect infected cells
(GFP-positive).
Colocalization experiments
For colocalization studies, we cloned the TVBS3 full-
length cDNA into the mammalian expression vector pEF6/
V5-His TOPO (Invitrogen). TVBS3 full-length cDNA was
amplified using PCR with the following oligonucleotide
primers: FD11 (TVBS3-5V) 5TGGACCAAACCCGTTCC-
TAACTCGG; FD12 (TVBS3-3V) 5-GCTCACCTCG-
TACTGGAAATAGCCC. The PCR-amplified fragment
was cloned into pEF6/V5-His TOPO following manufac-
turer directions (Invitrogen). This construct was transfected
into QT-6 cells using lipofectamine (Invitrogen). QT-6
cells stably expressing the tagged receptor were selected
by using Blasticidin 3 Ag/ml (Invitrogen). Single-cell
clones were obtained by seeding 30 cells on 96-well
plates. Cells were grown overnight on 12-mm diameter
coverslips and fixed in 3.9% paraformaldehyde (Sigma) in
phosphate-buffered saline (PBS; Cellgro) for 30 min. Cells
were washed in PBS, incubated in 0.1 M glycine (Sigma)
for 10 min, washed in PBS, and permeabilized with 0.05%
saponin (Sigma) for 30 min. Samples were blocked with
10% donkey serum (Dako) for 30 min and incubated for 1 h
with primary antibodies. Subsequently, cells were washed
with PBS and incubated with secondary antibodies.
Samples were mounted for fluorescence microscopy by
using the ProLong Antifade Kit (Molecular Probes). Images
were acquired by using a BioRad Radiance 2000 laser
scanning confocal microscope with Nikon 60  N.A.1.4
optics.
Immunoblotting
Cell lines were grown on 100-mm plates to a confluency
of 90%, and cell extracts were prepared with a homoge-
nization buffer (10 mM Tris [pH 7.5], 10 mM NaCl, 1 mM
EDTA) containing a cocktail of protease inhibitors (Roche,
Indianapolis, ID). Cells were subjected to Dounce-homog-
enization and centrifuged at 2,500  g to obtain post-
nuclear supernatants. We determined protein concentration
using a bicinchoninic acid protein assay reagent kit
(Pierce). Ten micrograms of protein was applied to a 10%
sodium dodecyl sulfate (SDS) polyacrylamide gel under
reducing conditions and transferred to nitrocellulose mem-
branes. The membranes were probed with SUB-IgG (to
detect TVBS3), anti-clathrin heavy chain antibodies, and
anti-caveolin-1 antibodies. Subsequently, filters were incu-
bated with horseradish peroxidase-conjugated anti-rabbit or
anti-mouse immunoglobulins as secondary antibodies
(Amersham Pharmacia). Antibody binding was detected
by using an enhanced chemiluminescence kit (Amersham
Pharmacia).
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Cells were grown on 12-mm coverslips and incubated
with SUB-IgG at 4 -C for 1 h. Internalization was induced
by incubating cells at 37 -C in the presence or absence of
50 AM chlorpromazine for different times. Samples were
fixed in 3.9% paraformaldehyde (Sigma) in phosphate-
buffered saline (PBS) for 30 min. Cells were washed with
PBS containing 0.1 M glycine (Sigma) for 10 min, washed
with PBS, and permeabilized with 0.05% saponin (Sigma)
for 30 min. Samples were blocked with 10% donkey serum
for 30 min (Dako), and SUB-IgG was identified using anti-
rabbit Cy3-labeled secondary antibodies (Jackson Immu-
noresearch). Samples were mounted for fluorescence
microscopy on coverslips by using the ProLong Antifade
Kit (Molecular Probes). Images were acquired by using a
BioRad Radiance 2000 laser scanning confocal microscope
with Nikon 60  N.A. 1.4 optics.
Fractionation of detergent-resistant membranes
A total of 107 DF-1 cells were washed with ice-cold PBS
and then with 37 -C prewarmed serum-free media.
Subsequently, cells were incubated with 2 ml of ice-cold
MBS lysis buffer (25 mM morpholine ethanesulfonic acid,
150 mM NaCl, 0.5% Triton-X-100, pH 6.5). The cell lysate
was adjusted to 40% sucrose by addition of 2 ml of 80%
sucrose solution, and a 1-ml aliquot of this mixture was
overlaid with 3.5 ml of 30% sucrose followed by 0.5 ml of
5% sucrose (sucrose solutions were prepared in MBS).
Samples were centrifuged at 240,000  g for 18 h at 4 -C in
a Beckman SW55Ti rotor. Fractions were collected from the
sucrose gradient and mixed in a 1:1 ratio with 2  SDS
sample buffer, boiled, and subjected to SDS–polyacryla-
mide gel electrophoresis. TVBS3 was detected by Western
blotting using SUB-rIgG and a horseradish peroxidase-
coupled secondary anti-rabbit antibody (Amersham Phar-
macia). Caveolin-1 was detected by using an N-20 anti-
caveolin-1 antibody (Santa Cruz Biotechnology).Acknowledgments
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